IL6 and glioma: Studies have also shown that interleukin (IL)-6 released by GAMs can significantly enhance the permeability of the blood–brain barrier in glioma patients by activating the JAK-STAT3 pathway in endothelial cells and downregulating the level of intercellular connexins, which leads to the formation of vasogenic brain edema (20).